Atlas Trials

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma

Clinical trial NCT00004244 · COMPLETED

Trial details

NCT number
NCT00004244
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Kidney CancerMelanoma (Skin)
Start date
2000-03-01
Primary completion
2005-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.